Company overview

NeoGenomics, Inc. is a premier cancer diagnostics company specializing in cancer genetics testing and oncology data solutions. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. Headquartered in Fort Myers, FL, NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories for full-service sample processing and analysis services throughout the US and a CAP-accredited full-service, sample-processing laboratory in Cambridge, England, United Kingdom.
Founded in 2002
Fort Myers, Florida, USA
1.7K employees (24 in marketing)
53% recommend to a friend
45% positive business outlook

Salaries

Help build salary transparency at NeoGenomics Laboratories

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

3 open now

Headcount trend

Company growth over the last 12 months

Headcount +8% year over year

Funding

Total funding

$925.9M

Last raise

$200M

Post IPO Equity, 5 years ago

Funding history

May 2021

Post IPO Equity NeoGenomics · $200M

Apr 2020

Post IPO Equity NeoGenomics · $125.4M

Apr 2020

Post IPO Debt NeoGenomics · $175M

May 2019

Post IPO Equity NeoGenomics · $150M

Aug 2018

Post IPO Equity NeoGenomics · $125M

Dec 2016

Post IPO Debt NeoGenomics · $150M

Audience

Monthly website visitors
38.3K
Month over month-25.8%
Quarter over quarter-15.4%
Top sourceSearch (48.2%)
Ad budget per month$3.1K
Average search rank43.4
Traffic source mix
Search
48.2%
Direct
44.5%
Referral
6.1%
Social
0.6%
Paid referral
0.5%

LinkedIn followers

Follower count and growth

Total followers

62.7K

12-mo growth

Monthly growth

+5.9%

News

Links